Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruin Moaddel

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Plos One|August 17, 2013
Long-term artificial sweetener acesulfame potassium treatment alters neurometabolic functions in C57BL/6J miceWei-na Cong, Rui Wang, Huan Cai, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
British Journal of Pharmacology|April 4, 2019
(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic dosesPanos Zanos, Jaclyn N Highland, Xin Liu, et al.
Aging Cell|March 10, 2025
Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in OctogenariansCeereena Ubaida-Mohien, Ruin Moaddel, Sally Spendiff, et al.
ACS Chemical Neuroscience|February 3, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketaminesJaclyn N Highland, Patrick J Morris, Kylie M Konrath, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Lipids in Health and Disease|January 10, 2019
Serum lipids in adults with late age-related macular degeneration: a case-control studyRichard D Semba, Ruin Moaddel, Mary Frances Cotch, et al.
Research Square|February 26, 2026
Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy VolunteersJenessa Johnston, Greg Jones, Shiyong Peng, et al.
The Journal of Biological Chemistry|November 3, 2012
Alcohol-induced one-carbon metabolism impairment promotes dysfunction of DNA base excision repair in adult brainAnna-Kate Fowler, Aveline Hewetson, Rajiv G Agrawal, et al.
Pharmacological Reviews|March 6, 2021
Hydroxynorketamines: Pharmacology and Potential Therapeutic ApplicationsJaclyn N Highland, Panos Zanos, Lace M Riggs, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Plos One|August 17, 2013
Long-term artificial sweetener acesulfame potassium treatment alters neurometabolic functions in C57BL/6J miceWei-na Cong, Rui Wang, Huan Cai, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
British Journal of Pharmacology|April 4, 2019
(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic dosesPanos Zanos, Jaclyn N Highland, Xin Liu, et al.
Aging Cell|March 10, 2025
Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in OctogenariansCeereena Ubaida-Mohien, Ruin Moaddel, Sally Spendiff, et al.
ACS Chemical Neuroscience|February 3, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketaminesJaclyn N Highland, Patrick J Morris, Kylie M Konrath, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Lipids in Health and Disease|January 10, 2019
Serum lipids in adults with late age-related macular degeneration: a case-control studyRichard D Semba, Ruin Moaddel, Mary Frances Cotch, et al.
Research Square|February 26, 2026
Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy VolunteersJenessa Johnston, Greg Jones, Shiyong Peng, et al.
The Journal of Biological Chemistry|November 3, 2012
Alcohol-induced one-carbon metabolism impairment promotes dysfunction of DNA base excision repair in adult brainAnna-Kate Fowler, Aveline Hewetson, Rajiv G Agrawal, et al.
Pharmacological Reviews|March 6, 2021
Hydroxynorketamines: Pharmacology and Potential Therapeutic ApplicationsJaclyn N Highland, Panos Zanos, Lace M Riggs, et al.
Pageof 22